DSS Announces Licensing of Impact BioMedical s Linebacker Portfolio to ProPhase Labs forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
ProPhase Labs Announces Licensing of New Investigational Cancer Compounds streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
ROCHESTER, N.Y., July 21, 2022 (GLOBE NEWSWIRE) DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and.
ProPhase Labs Announces Formation of ProPhase BioPharma, Inc. (PBIO) for the Licensing and Development of Novel Drugs, Compounds and Biotechnology - read this article along with other careers information, tips and advice on BioSpace